News

Researchers Synthesize Caffeine-Like Compounds to Fight Parkinson’s

Researchers have synthesized two compounds that resemble caffeine and prevent the misfolding of alpha-synuclein — the culprit of neurodegeneration in Parkinson’s disease. These compounds were shown to effectively prevent the cells from dying. The findings by researchers from University of Saskatchewan in Canada advance the understanding of processes that…

Scientists Develop Stem Cell Strategy Against Parkinson’s Without Need for Transplant

Researchers have developed a new “cell-free” approach — one derived from stem cells — that may treat Parkinson’s disease while avoiding the immune system risks of other stem cell therapies, according to two studies conducted by researcher Leo Behie, from the University of Calgary, in Canada, and collaborators in Portugal. The newly developed…

Premarketing OK Granted for Parkinson’s Second Generation KinetiGraph

 Global Kinetics Corporation, specialized in developing health technology for people with Parkinson’s disease, has received premarketing clearance from the U.S. Food and Drug Administration (FDA) for the next generation of its wrist-worn Personal KinetiGraph (PKG) system. The PKG records movement symptoms of the Parkinson’s wearer, provides programmed medication…

Parkinson’s Researchers Shed Light on Brain Area Controlling Eye Movements

Swedish researchers report that the massive burden of prioritizing visual stimuli from our environment lies with the the superior colliculus area of the brain. This ancient part of the brain may provide clues regarding the mechanisms leading to Parkinson’s disease, where patients often have impaired eye movement. The Karolinska Institute research paper, “Spatiotemporal interplay between…